Core infrastructure support
Ended Awarded Last action
- Contract number
- HHSN26100009
- Awardee
-
Mayo Clinic UEI Y2K4F9RPRRG7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,665,425
Award facts
- Opportunity
-
- N01CN0501469 Solicitation number
- Contract value 100% obligated
- $3,665,424.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Rochester, MN 55905, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$24,816 | |
| Funding Only Action | -$23,501 | |
| Supplemental Agreement for work within scope | $369,112 | |
| Supplemental Agreement for work within scope | $848,703 | |
| Exercise an Option | $855,261 | |
| Exercise an Option | $831,537 | |
| Other Administrative Action | $11,407 | |
| Original award | $797,722 |
About this award
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a delivery order contract worth $3,665,424.78 to the Mayo Clinic, a large non-profit academic medical center focused on integrated clinical practice, education, and research. The contract is to provide core infrastructure support for the Cancer Prevention Agent Development Program's Early Phase Clinical Research efforts. This award is not a set-aside contract. Mayo Clinic has extensive experience supporting federal agencies like the NIH, DoD, and FDA through prime contracts and grants, including providing pharmacokinetic assessments, analytical services, and developing purified exosome products. The National Cancer Institute has also awarded Mayo Clinic a $9.9 million indefinite delivery/indefinite quantity (IDIQ) contract to procure research and development services supporting preclinical pharmacokinetic and pharmacology evaluations for the Experimental Therapeutics program.
Quick answers
Who was awarded contract HHSN26100009?
HHSN26100009 was awarded to Mayo Clinic by National Cancer Institute (National Institutes of Health) on September 24, 2015.
How much is contract HHSN26100009 worth?
The government has obligated $3,665,425 on HHSN26100009.
Is contract HHSN26100009 an order under another contract?
Yes. HHSN26100009 is a delivery order under HHSN261201200042I, an indefinite delivery contract.
Was contract HHSN26100009 competed?
The extent of competition for HHSN26100009 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award